$-0.04 EPS Expected for Amphastar Pharmaceuticals, Inc. (AMPH)

Stephen Andrade

Investors sentiment increased to 0.91 in 2017 Q3. Its up 0.15, from 0.76 in 2017Q2. It is positive, as 11 ...

Adaptimmune Therapeutics plc (ADAP) Analysts See $-0.25 EPS

Marguerite Chambers

Analysts expect Adaptimmune Therapeutics plc (NASDAQ:ADAP) to report $-0.25 EPS on March, 12.They anticipate $0.03 EPS change or 13.64 % ...

Laffer Investments Decreased Spectra Energy Partners Lp (NYSE:SEP) Stake By $56.46 Million

Michael Pereira

Investors sentiment decreased to 1.13 in Q3 2017. Its down 0.15, from 1.28 in 2017Q2. It is negative, as 19 ...

EPS for VolitionRx Limited (VNRX) Expected At $-0.16

Winifred Garcia

Investors sentiment increased to 7 in Q3 2017. Its up 3.00, from 4 in 2017Q2. It increased, as 0 investors ...

Investec Asset Management Ltd Decreased Washington Federal Inc (NASDAQ:WAFD) Stake By $21.37 Million

Jan Rainey

Investors sentiment decreased to 0.89 in Q3 2017. Its down 0.32, from 1.21 in 2017Q2. It fall, as 12 investors ...

EPS for Vericel Corporation (VCEL) Expected At $-0.10

Kurt Siggers

Analysts expect Vericel Corporation (NASDAQ:VCEL) to report $-0.10 EPS on March, 9.They anticipate $0.04 EPS change or 28.57 % from ...

EPS for Urstadt Biddle Properties Inc. (UBA) Expected At $0.33

Michael Collier

Investors sentiment increased to 1.29 in Q3 2017. Its up 0.10, from 1.19 in 2017Q2. It improved, as 9 investors ...

Trillium Therapeutics Inc. (TRIL) Analysts See $-0.89 EPS

Marguerite Chambers

Analysts expect Trillium Therapeutics Inc. (NASDAQ:TRIL) to report $-0.89 EPS on March, 9.They anticipate $0.03 EPS change or 3.49 % ...

« Previous PageNext Page »

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: